Book a free demo with us
Book Now
Evogene
Evogene (NASDAQ:EVGN, TASE: EVGN.TA) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform.
Content Locked
Login or Register a FREE account to continue browsing our content
2022
Rehovot, IsraelIsrael
Genetic
Biotechnology
51 - 200
Post-IPO EquityWebsite
| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content
Evogene's
Key Team Members
Founder
%2Fuploads_startups%2Fuser_uploads%2Fteam_members%2F8Aw12BPt8LVl00oJXSIhadrKLRscIi98AlTfDTj4.jpg&w=3840&q=75)
Register for our free weekly newsletter
Stay up to date with the latest news, special reports, videos, infobytes, and features on the region's most notable entrepreneurial ecosystems